From Antigen to Antibody: Accelerated, Scalable, and High-Quality Solutions
Syngene delivers comprehensive antibody generation and production services across polyclonal, hybridoma, and recombinant platforms. Whether for research, preclinical, or commercial programs, we help you design, produce, and scale with confidence.
From Antigen to Antibody: Accelerated, Scalable, and High-Quality Solutions
Syngene delivers comprehensive antibody generation and production services across polyclonal, hybridoma, and recombinant platforms. Whether for research, preclinical, or commercial programs, we help you design, produce, and scale with confidence.
From polyclonal to recombinant monoclonal antibodies, Syngene offers a full spectrum of solutions to match your research and development goals. Each approach is designed to deliver reliable quality, scalability, and scientific precision.
Polyclonal Antibody Production
Immunization in New Zealand White rabbits for high-yield antibody generation
Supports diverse antigen formats including bacteria, proteins, and peptides
Purification using Protein A/G affinity chromatography for superior specificity
Hybridoma Technology
Comprehensive expertise in conjugation, immunization, animal handling, and titer evaluation
Hybridoma development to generate stable antibody-producing cell lines
Advanced ELISA and Biacore screening to isolate high-affinity, target-specific clones
Recombinant Monoclonal Antibody Generation
Gene cloning from hybridomas or sequence data for precision engineering
High-expression constructs developed through advanced plasmid engineering
Transient expression in HEK293 cells and CHO stable cell line development
Scalable production pathways to support both research-scale and clinical-grade needs
How It Works
Our antibody production workflow is designed to give you clarity, flexibility, and confidence at every stage. From concept to scale-up, we apply scientific rigor and proven processes to deliver high-quality results.
Antigen Design & Strategy Selection
We collaborate with you to design the right immunogen and select the most effective approach based on target type and project goals.
Immunization or Cloning Workflows
Depending on the program, we execute tailored immunization protocols or recombinant cloning strategies to generate diverse antibody candidates.
Screening & Characterization
Advanced platforms such as ELISA and Biacore are used to identify and validate antibodies with optimal specificity, affinity, and functionality.
Purification & Validation
Antibodies are purified using industry-standard methods and validated for reproducibility and quality, ensuring consistent performance.
Scale-Up for Applications
Once validated, antibodies can be seamlessly scaled for preclinical, diagnostic, or commercial use, with smooth transition into GMP manufacturing when required.
The Syngene Advantage: Built for Reliability and Scale
Syngene’s antibody production services are built to give you speed, reliability, and confidence at every stage.
Beyond Antibody Production:
Integration with Broader Syngene Capabilities
At Syngene, antibody production is only the first step. Our comprehensive biologics ecosystem allows you to seamlessly advance your program from discovery through commercialization—reducing handoffs, saving time, and ensuring consistency.
Antibody-Drug Conjugates (ADCs): Expertise in linker-payload design and development to accelerate therapeutic innovation.
Bispecific Antibodies: Advanced platforms to engineer and produce bispecifics with high specificity and stability.
Bioanalytical Testing: Robust validation and characterization services to meet regulatory requirements with confidence.
GMP Manufacturing: State-of-the-art facilities for clinical and commercial supply, ensuring global compliance and scalability.
Ready to Accelerate Your Antibody Program?
From antigen design to large-scale GMP manufacturing, Syngene delivers the expertise, technology, and scale.
Move your project forward faster and with confidence.